The current study on the optimization of Solarise drugs and pharmacokinetics is being conducted, and it is being applied to the treatment of squamous cell head and neck cancer in animal models. The goal is to obtain more in-depth efficacy and safety data of Solarise in animals, which can also be expanded for clinical trials in humans with squamous cell carcinoma of other organs, such as head and neck cancers and gynecological cancers.
